Search

Your search keyword '"G, Russi"' showing total 170 results

Search Constraints

Start Over You searched for: Author "G, Russi" Remove constraint Author: "G, Russi"
170 results on '"G, Russi"'

Search Results

1. Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide

2. Dysphagia in Head and Neck Cancer Patients: Pretreatment Evaluation, Predictive Factors, and Assessment during Radio-Chemotherapy, Recommendations

3. Letter from Italy: First practical indications for radiation therapy departments during COVID-19 outbreak

4. The value of prostate-specific antigen monitoring during salvage radiotherapy: a retrospective study and systematic review with meta-analysis

5. Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model

6. Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?

7. Local and Systemic Pathogenesis and Consequences of Regimen-Induced Inflammatory Responses in Patients with Head and Neck Cancer Receiving Chemoradiation

8. Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study

9. Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC)

10. Predictive value of Prostate Specific Antigen variations in the last week of salvage radiotherapy for biochemical recurrence of prostate cancer after surgery: A practical approach

11. Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic

12. Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy

13. A new standardized data collection system for interdisciplinary thyroid cancer management: Thyroid COBRA

14. Management of patients with cardiac implantable electronic devices (CIED) undergoing radiotherapy

15. PH-0040: A 6-point scale approach to 18F-FDG PET-CT for response assessment in HNSCC: a multicenter study

16. Artificial intelligence and radiomics enhance the positive predictive value of digital chest tomosynthesis for lung cancer detection within SOS clinical trial

17. Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

18. Does a 6-point scale approach to posttreatment 18F-FDG PET-CT allow to improve response assessment in head and neck squamous cell carcinoma? A multicenter study

19. Extreme hypofractionation for early prostate cancer: Biology meets technology

20. Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) survey

21. Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy

22. E1 Detection as Prognosticator in Human Papillomavirus-Positive Head and Neck Cancers

23. Correlation of TP53 and MDM2 Genotypes and Clinical Outcome in Platinum-Treated Head and Neck Cancer Patients with More than 10 Years’ Follow-Up

24. Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies

25. Letter to the editor regarding Wei W et al.: 'Experience of the Hubei cancer hospital in Wuhan, China'

26. Dose prescription in SBRT for early-stage non-small cell lung cancer: are we all speaking the same language?

27. Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity

28. Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study

29. Linee guida Carcinoma della Prostata - AIRO, 2016

30. External Beam Radiotherapy in Thyroid Carcinoma: Clinical Review and Recommendations of the AIRO 'Radioterapia Metabolica' Group

31. Pros and Cons of the New Edition of TNM Classification of Head and Neck Squamous Cell Carcinoma

32. Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide

33. A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies

34. The outstanding evolution of radical prostatectomy in the last seven years in italy: Comparative analysis on more than 1,500 patients from MIRROR-SIU/LUNA vs. Pros-IT-CNR surveys

35. The waiting list for prostate cancer treatment in italy: Analysis from the Pros-IT CNR survey

36. A new approach for the pixel map sensitivity (PMS) evaluation of an electronic portal imaging device (EPID)

37. Role of IL-8 induced angiogenesis in uveal melanoma

38. A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy : A systematic review by the Italian Head and Neck Radiotherapy Study Group

39. What is the role of postoperative re-irradiation in recurrent and second primary squamous cell cancer of head and neck? A literature review according to PICO criteria

40. The Role of Neck Dissection after Radical Chemoradiation for Locally Advanced Head and Neck Cancer: Should We Move Back?

41. Non-surgical organ preservation strategies for locally advanced laryngeal tumors: what is the Italian attitude? Results of a national survey on behalf of AIRO and AIOM

42. Combination of bevacizumab and irradiation on uveal melanoma: an in vitro and in vivo preclinical study

43. PO-0754: ISIORT pooled analysis 2016: characteristics of intraoperative radiotherapy in 11,025 patients

44. Survival prediction and frequency of anticancer treatment in cancer patients hospitalized due to acute conditions. Role of clinical parameters and PaP score

45. Management of Skin Toxicity Associated with Cetuximab Treatment in Combination with Chemotherapy or Radiotherapy

46. Advances in EGFR-directed therapy in head and neck cancer

47. Treatment of symptomatic HyperLp(a)lipoproteinemia with LDL-apheresis: a multicentre study

48. The process of truth disclosure: an assessment of the results of information during the diagnostic phase in patients with cancer

49. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement

50. Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations

Catalog

Books, media, physical & digital resources